PBIRx

06/04/2026

Today! Still time to join our PBIRx Webinar: : The New Savings Frontier. Explore the Biosimilar market landscape, regulatory influences, PBM vendor strategies and challenges. Register here: https://zoom.us/webinar/register/WN_wzx5TEf4TfWpJwVPdhL5QA #/registration

06/03/2026

PBIRx Executive VP, David Sirowich, sharing more than 30 years of pharmacy benefit expertise and insights as a featured panelist on the future of Rx at the MA 2026

06/02/2026

Join our PBIRx Webinar - : The New Savings Frontier. This webinar will explore the Biosimilar market landscape, regulatory influences, PBM vendor strategies and challenges. Register here: https://zoom.us/webinar/register/WN_wzx5TEf4TfWpJwVPdhL5QA #/registration

05/29/2026

PBIRx is proud to be named the new for both Attleboro & Hampshire County Group Insurance Trust to assist them in optimizing their pharmacy spend during this turbulent period of the pharmacy landscape. PBIRx partners with many municipalities & groups to ensure they stay ahead of the trends & surprise costs of specialty drugs. WSJ article linked here:

Municipal employers are stripping coverage as financial concerns mount.

05/27/2026

“To protect PBIRx’s clients’ information from a hack, PBIRx invests heavily in retaining an outside firm every year to put us and our systems to the test,” said PBIRx President and Founder, Patricia Sirowich. Read our press release:

PBIRx announced it again achieved SOC 2 Type 2 and SOC 3 attestations, reinforcing its commitment to top compliance and integrity standards.

05/21/2026

, the new Eli Lilly weight loss drug nicknamed Triple-G, targets 3 key hormones: – reducing appetite, GIP – improving insulin function, and Glucagon – increasing calorie burn. Currently in Phase 3 of the TRIUMPH-1 clinical trial, Retatrutide is expected to get approval the end of 2026 or early 2027. It is too early to predict the drug price. https://lilly.mediaroom.com/2026-05-21-Lillys-triple-agonist,-retatrutide,-delivered-powerful-weight-loss-in-pivotal-Phase-3-obesity-trial?utm_source=x&utm_medium=organicsocial&utm_campaign=cy26_cmh-overallsite-lilly_reach&utm_content=7310&utm_term=

05/21/2026

PBIRx – Committed to Learning! PBIRx - connecting at with other specialty pharmacy leaders - exchanging insights on regulatory reforms from legislation to ex*****on. PBIRx helps our clients maximize pharmacy benefit savings with key insight on transparency & emerging health care trends, always with a keen focus on member satisfaction.

05/20/2026

adds more than 600 generic medications to the direct-to-consumer website. PBIRx is always monitoring & evaluating new opportunities to lower drug costs for our clients with timely guidance. Story linked here:

How TrumpRx may help you save money on prescription drugs — and other ways to lower the cost of your medications.

05/11/2026

It’s ! PBIRx recognizes our many hospital & health system clients & the innovative ways they support & connect to our communities! Read our case study to learn how PBIRx saved one hospital client $1.2 million on https://pbirx.com/2022/06/16/non-profit-hospital/

05/07/2026

Breaking: to carry at US kiosks, offer same-day delivery. PBIRx works with our clients to advise management options for to maximize member benefit at the lowest net cost. Read story here

Amazon.com said on Thursday its pharmacy will stock Novo Nordisk's Ozempic pill to treat type 2 diabetes at its kiosks and offer ​same-day delivery of the drug